KR100711954B1 - Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin - Google Patents

Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin Download PDF

Info

Publication number
KR100711954B1
KR100711954B1 KR1020060091978A KR20060091978A KR100711954B1 KR 100711954 B1 KR100711954 B1 KR 100711954B1 KR 1020060091978 A KR1020060091978 A KR 1020060091978A KR 20060091978 A KR20060091978 A KR 20060091978A KR 100711954 B1 KR100711954 B1 KR 100711954B1
Authority
KR
South Korea
Prior art keywords
ginseng
saponin
content
wild ginseng
cultured
Prior art date
Application number
KR1020060091978A
Other languages
Korean (ko)
Inventor
백기엽
한은주
정철승
Original Assignee
주식회사 씨비엔바이오텍
백기엽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 씨비엔바이오텍, 백기엽 filed Critical 주식회사 씨비엔바이오텍
Priority to KR1020060091978A priority Critical patent/KR100711954B1/en
Application granted granted Critical
Publication of KR100711954B1 publication Critical patent/KR100711954B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/001Culture apparatus for tissue culture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/11Preparation or pretreatment of starting material involving culturing conditions, e.g. cultivation in the dark or under defined water stress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

본 발명은 사포닌이 다량 함유된 산삼배양근 추출물에 관한 것으로서, 더욱 상세하게는, 조직배양에 의해 증식된 산삼 부정근을 배지에 접종하고 생물반응기내에서 배양하되, 수확 10일전경 배지내 질소를 고갈시킨 다음 배양하여 수득한 산삼배양근 분말을 가온추출법 또는 냉각환류추출법으로 추출하여 사포닌 함량이 높은 산삼배양근 추출물에 관한 것이다.The present invention relates to a ginseng cultured root extract containing a large amount of saponin, and more particularly, inoculated in wild ginseng roots grown by tissue culture in a medium and cultured in a bioreactor, but depleted of nitrogen in the medium around 10 days after harvesting. Next, the ginseng culture root powder obtained by culturing is extracted by a warm extraction method or a reflux extraction method and relates to a ginseng culture root extract having high saponin content.

본 발명에 따른 산삼배양근 추출물은 주요 약리 활성성분인 사포닌이 다량 함유된 기능성식품 소재로서, 산삼 사포닌에서 유래한 다양한 건강상 유익뿐만 아니라, 특히 현대인에게 많이 생기는 활성산소종을 효과적으로 제거할 수 있는 효과가 있는 것으로 평가되었다.The ginseng cultured root extract according to the present invention is a functional food material containing a large amount of saponin, which is a major pharmacologically active ingredient, and not only various health benefits derived from wild ginseng saponin, but also an effect that can effectively remove active oxygen species that occur a lot in modern people Was evaluated.

산삼, 배양근, 추출물, 사포닌 Wild ginseng, culture root, extract, saponin

Description

사포닌 함량이 높은 산삼배양근 추출물{Extract of Tissue Cultured Mountain Ginseng(Panax schinseng NESS) Having High Content Saponin}Extract of Tissue Cultured Mountain Ginseng (Panax schinseng NESS) Having High Content Saponin}

도 1은 본 발명의 산삼배양근 추출물의 조사포닌 특성을 보여주는 크로마토그램이다.1 is a chromatogram showing the irradiated ponson characteristics of wild ginseng cultured root extract of the present invention.

도 2는 본 발명의 산삼배양근 추출물의 배양공정 조절을 통한 산삼배양근의 사포닌 함량조절 크로마토그램이다.Figure 2 is a chromatogram of saponin content control of wild ginseng culture root by adjusting the culture process of wild ginseng culture root extract of the present invention.

도 3은 본 발명의 산삼배양근 추출물의 DPPH 소거활성을 보여주는 그래프이다.Figure 3 is a graph showing the DPPH scavenging activity of wild ginseng cultured root extract of the present invention.

본 발명은 사포닌이 다량 함유된 산삼배양근 추출물에 관한 것으로서, 더욱 상세하게는, 조직배양에 의해 증식된 산삼 부정근을 배지에 접종하고 생물반응기내에서 배양하되, 수확 10일전경 배지내 질소를 고갈시킨 다음 배양하여 수득한 산삼배양근 분말을 가온추출법 또는 냉각환류추출법으로 추출하여 사포닌 함량이 높은 산삼배양근 추출물에 관한 것이다.
인삼(Panax ginseng)은 오갈피나무과(Araliaceae)에 속하는 다년생 초본류로서, 한방에서는 그 뿌리를 인삼(Ginseng Radix)이라 하며 강장(强壯), 강정(强精), 조혈(造血), 보온(保溫), 건위(健胃), 피로회복, 정신안정, 진정작용 등의 효능이 있는 것으로 알려져 있다 (고려인삼의 효능요약집, 한국인삼연구소, 대성인쇄사, p143, 1985). 이러한 인삼의 주요 유효성분으로는 사포닌, 사포게닌, 폴리아세틸렌, 피라진 유도체, 말톨 등이 있으며, 인삼 사포닌은 화학구조의 특성에 따라 프로토파낙사디올(protopanaxadiol)계, 프로토파낙사트리올(protopanaxatriol)계 및 올레아노난(oleanonane)계 사포닌으로 구분하는데, 현재까지 각각 19종, 10종, 1종의 화합물이 분리 정제되었으며, 디올계와 트리올계는 체내에서의 약리작용이 서로 다른 것으로 알려져 있다. 인삼 사포닌은 다른 식물의 사포닌과 달리 독성이 없고 0.001% 이하에서는 용혈작용을 나타내지 않는 것으로 알려져 있으며 (田中治, 藥用人蔘共立出版, p43, 1981), 중추신경 억제작용 (Tanaki, K. et al., J. Pharmacol. 33: 245, 1972), 단백질합성 촉진작용 (Yokozawa, T. and Oura, H., J. Nat. Prod. 53: 1514, 1990), 부신피질호르몬 분비촉진작용 (Pearec, P. T. et al., Endocrinol. 29: 567, 1982), 면역증강작용 (Kim, Y.S. et al., Korean J. Ginseng Sci. 15: 13, 1991) 등이 있는 것으로 보고되고 있다.
한편, 산삼(Panax schinseng NESS)은 산에 자연적으로 나는 인삼으로, 적응증이나 효용은 인삼과 비슷하나 그 약효가 월등히 뛰어나며, 대표적인 효능으로는 신체 조절 기능의 항상성 유지 작용이라 할 수 있다. 이러한 작용에 근거하여 항피로 및 항스트레스 작용, 혈압조절 작용, 항암작용, 동맥경화 및 고혈압의 예방, 위장기능 강화, 면역기능 강화, 항바이러스 작용 등이 보고되고 있다.
상기와 같이 다양한 약리 효능을 가지고 있는 인삼 또는 산삼은 의약품, 식품 및 화장품 등에 유용하게 사용되나, 천연 약용 인삼 또는 산삼은 대량생산이 불가능하며, 고가이므로 비경제적이다. 따라서 비고가의 약용 인삼 및 산삼을 식물 조직 배양 기술을 이용하여 대량 배양하는 연구가 행해지고 있으며, 본 발명자에 의한 한국특허출원 제2001-0003285호는 조직 배양에 의한 인삼, 장뇌삼, 산삼 부정근의 대량 증식방법에 관하여 개시하고 있다. 또한, 본 발명자는 조직 배양을 통해 수득한 부정근이 대량 생산은 가능하지만 자연삼에 비해 사포닌 함량이 낮고, 디올 및 트리올의 비율이 자연삼에 비해 큰 차이가 나는 문제점을 개선하기 위하여, 조직 배양에 의한 인삼, 장뇌삼, 산삼 부정근의 사포닌 함량 개선 방법에 관하여 한국특허출원 제2001-0003284호에 개시한 바 있다.
The present invention relates to a ginseng cultured root extract containing a large amount of saponin, and more particularly, inoculated in wild ginseng roots grown by tissue culture in a medium and cultured in a bioreactor, but depleted of nitrogen in the medium around 10 days after harvesting. Next, the ginseng culture root powder obtained by culturing is extracted by a warm extraction method or a reflux extraction method and relates to a ginseng culture root extract having a high saponin content.
Panax ginseng is a perennial herb belonging to the Araliaceae family, and its root is called Ginseng Radix in oriental medicine. Tonic, Gangjeong, Hematopoietic, Warmth, It is known to have the effects of healthy stomach, fatigue, mental stability, sedation (Korea Ginseng Efficacy Summary, Korea Ginseng Research Institute, Daesung Printing Co., p143, 1985). The main active ingredients of ginseng include saponins, sapongenins, polyacetylenes, pyrazine derivatives, maltol, and the like, and ginseng saponins are based on the chemical structure of protopanaxadiol and protopanaxatriol. It is divided into system and oleanonane-based saponins. To date, 19, 10 and 1 compounds have been separated and purified, and diol and triol are known to have different pharmacological effects in the body. Ginseng saponins, unlike other plant saponins, are not toxic and do not show hemolytic activity below 0.001% (Taiki, K. et al., P43, 1981). al., J. Pharmacol. 33: 245, 1972), protein synthesis (Yokozawa, T. and Oura, H., J. Nat. Prod. 53: 1514, 1990), corticosteroid secretion (Pearec) , PT et al., Endocrinol. 29: 567, 1982) and immunopotentiation (Kim, YS et al., Korean J. Ginseng Sci. 15: 13, 1991).
On the other hand, wild ginseng ( Panax schinseng NESS) is a ginseng naturally occurring in the mountains, indications and benefits are similar to ginseng, but its medicinal effect is excellent, and the representative effect is the homeostasis maintenance function of the body control function. Anti-fatigue and antistress action, blood pressure control action, anticancer action, arteriosclerosis and hypertension prevention, gastrointestinal function enhancement, immune function enhancement, antiviral action and the like have been reported based on this action.
Ginseng or wild ginseng having various pharmacological effects as described above is usefully used in medicines, foods, and cosmetics, but natural medicinal ginseng or wild ginseng is not economical because it is impossible to mass produce. Therefore, studies have been conducted to mass-reduce non-expensive medicinal ginseng and wild ginseng using plant tissue culture technology, and Korean Patent Application No. 2001-0003285 by the present inventors discloses mass growth of ginseng, camphor ginseng, and wild ginseng root muscle by tissue culture. The method is disclosed. In addition, the inventors of the present invention, in order to improve the problem that the mass of the negative root obtained through tissue culture is possible to mass production, but the saponin content is lower than that of natural ginseng, and the ratio of diol and triol is significantly different than that of natural ginseng, tissue culture The method for improving the saponin content of ginseng, camphor ginseng, and wild ginseng roots by the Korean Patent Application No. 2001-0003284 has been disclosed.

본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명의 목적은 건강기능성식품 소재로서 사포닌 특성에 따른 기능성이 개선된 사포닌 함량이 높은 산삼배양근 추출물을 제공하는 것이다.
본 발명의 다른 목적은 건강기능성식품 소재로서 우수한 건강기능성식품적 특성을 지닌 사포닌 함량이 높은 산삼배양근 추출물을 제공하는 것이다.
The present invention has been made in accordance with the requirements as described above, an object of the present invention is to provide a ginseng culture root extract with high saponin content improved functionality according to the saponin properties as a health functional food material.
Another object of the present invention is to provide a ginseng cultured root extract with high saponin content having excellent health functional food characteristics as a health functional food material.

이와 같은 목적을 달성하기 위한 본 발명은 사포닌이 다량 함유된 산삼배양근 추출물에 관한 것으로서, 더욱 상세하게는, 조직배양에 의해 증식된 산삼 부정근을 배지에 접종하고 생물반응기내에서 배양하되, 수확 10일전경 배지내 질소를 고갈시킨 다음 배양하여 수득한 산삼배양근 분말을 가온추출법 또는 냉각환류추출법으로 추출하여 사포닌 함량이 높은 산삼배양근 추출물에 관한 것이다.
본 발명의 산삼배양근 분말은 황색~황갈색의 분말의 성상에, 조사포닌의 평균 함량이 6.0~8.0 중량%, 총사포닌 함량이 2~3 중량%이며, 건조함량이 70~80 중량%인 것을 특징으로 한다.
또한, 상기 산삼배양근 분말은 평균 산도(pH)가 4.0~6.0인 것을 특징으로 한다.
또한, 상기 산삼배양근 분말의 중금속 기준이 3 ppm 미만인 것을 특징으로 한다.
또한, 상기 산삼배양근 분말의 증발잔류물은 4~6 중량%인 것을 특징으로 한다.
이하, 본 발명의 구성을 바람직한 실시예를 통하여 보다 상세히 설명할 것이나, 이들 실시예는 오로지 본 발명을 구체적으로 예시하기 위한 것으로서 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니며, 본 발명의 범위는 오직 특허청구범위에 기재된 바에 의해 한정되어야 할 것이다.
<실시예 1> 산삼배양근 추출물의 제조
강원도 오대산에서 2002년 10월 25일 채취한 약 100년 된 산삼을 뇌두, 주근, 세근으로 분리하고 각각을 멸균 소독한 후, 2~3㎟ 크기로 절편을 만든 다음 2,4-디클로로페녹시 아세트산(2,4-dichlorophenoxyacetic acid), 피클로람(pichloram), NAA (naphthalemeacetic acid) 각각을 1~10 ㎎/ℓ의 양으로 첨가한 후 MS 배지에 접종하고 캘러스를 유도하였다. 유도된 캘러스를 생장 조절제로 2,4-디클로로페녹시 아세트산을 1.0 ㎎/ℓ 첨가한 MS 배지에서 증식시킨 다음, 2주 간격으로 계대배양하면서 IBA를 5.0 ㎎/ℓ의 양으로 첨가한 MS 배지에 옮겨 부정근을 형성시켰다. 형성된 부정근을 다시 0.5~1 ㎝ 크기로 절단하여 10~20 L 용량의 생물반응기를 이용하여 무기물 농도 1/2, pH 5.7, 당농도 3%로 하는 MS 배지에 접종하여 18~25℃에서 부정근을 증식시킨 다음 큰 용량의 생물반응기 배양을 위한 씨드(seed)로 사용하였다. 상기 씨드(seed)를 1~2㎝ 크기로 절단하여 200, 500, 1,000, 10,000 L 규모의 대용량 공기 부양형 풍선형 생물반응기에 접종하여 증식하였다. 이때 배지조성은 5%의 당이 함유된 액체 MS배지(Duchefa사, 네들란드)를 사용하였고, 생장조절물질로는 3-인돌부틸산(IBA)을 1.0~5.0 ㎎/ℓ 첨가하였다. 배지의 초기 pH는 5.8~6.0, 배양온도는 22±2℃, 공기주입량은 0.1~0.3 vvm(volume/volume/min) 조건을 유지하였다.
배양 2주 후부터 부정근 절편에서 새로운 부정근이 형성되기 시작하여 배양 35~40일째 최대 증식이 이루어졌으며, 이 시기 이후 총사포닌 함량을 증가시키기 위해 배지내 질소를 고갈시킨 다음 10일 정도 더 배양하여 산삼의 뇌두, 주근, 세근으로부터 유도 증식된 배양근을 각각 수확하였으며, 이를 각각 CBN-1, CBN-2, CBN-3로 명명하였다. 수확된 시료는 수돗물로 2~3회 깨끗이 세척한 다음 50℃에서 24시간 건조한 후 분쇄기로 마쇄하여 분말 원료를 얻었다.
<실시예 2> 조직배양 산삼 분말의 건강기능성식품적 특성
조직배양 산삼 분말의 건강기능성식품으로서의 소질을 인정받기 위한 것으로 국내외적으로 배양산삼의 건강기능식품화 과정 및 공정에 대한 참고가 될 만한 사항을 찾아볼 수 없었기 때문에 우선 배양산삼을 원료로 하여 화장품 제조허가는 식약청으로부터 얻은 시험항목인 성상 및 확인, 총사포닌함량, 산도, 순도, 증발잔류물, 건조 감량 등을 시험항목으로 설정하여 건강기능성식품적 특성을 평가하였다.
상기 실시예 1에서 얻은 배양근 원료를 가온추출법을 이용하여 추출하였다. 즉, 조직배양한 산삼 부정근 10 ㎏을 80~100℃의 온도에서 6~8℃시간 추출하였으며, 이때 원료와 온수의 비율은 1:20으로 하였으며, 추출액을 약 55±2℃에서 진공 약 50㎜Hg로 에탄올을 제거하고 여과하여 산삼배양근 추출물 약 10㎏을 수득하였다.
상기 산삼배양근 분말 및 추출물을 대상으로 아래와 같이 상기 시험항목들을 조사하였다.
⑴ 성상은 직접 육안으로 관찰하고 냄새로서 판정하였다.
⑵ 확인시험은 사포닌류 확인을 위하여 원료 0.2 g에 무수초산 2 ㎖을 넣고 중탕으로 2분간 가온한 다음 여과한 여액 1 ㎖에 황산 0.5 ㎖를 넣었다. 아미노산 확인을 위하여 원료 2 ㎖에 닌히드린시액 1 ㎖를 넣고 흔들어 섞은 후 중탕한 끓는 물에 5~10분간 방치하였다. 트리테르펜노이드 확인을 위하여 위의 추출액 10 ㎖을 감압 농축한 다음 잔류물에 클로로포름 10 ㎖을 가해 흔들어 섞은 후 여과하고, 이 액 0.5 ㎖에 무수초산 0.5 ㎖를 첨가하여 섞어준 후 황산 0.5 ㎖를 유리관 표면에 첨가한다.
⑶ 사카라이드 확인을 위하여 0.5 ㎖에 5% α-나프톨에탄올 시액 2~3방울을 넣고 섞은 다음 황산 2 ㎖에 첨가한 후 흔들지 말고 방치하여 확인하였다.
⑷ 총사포닌함량은 식품공전원 표준 분석법에 따라 함량을 분석하였다.
⑸ 산도(pH)는 원료 5 g을 측정하여 새로 증류한 물을 상온에서 냉각시킨 다음 넣어 50㎖로 만들어 측정하였다.
⑹ 순도시험은 중금속 함량을 확인하기 위해 원료 1 g을 취하여 제2법에 따라 조작하여 실험하였다. 비교액에는 납표준액 2.0 ㎖을 넣어 감별하였으며 (20ppm 이하), 비소를 검출하여 위해서는 원료 1 g을 취하여 제3법에 따라 검액을 만들고 장치 A를 쓰는 방법에 따라 조작하여 실험하여 확인하였다(2ppm 이하).
⑺ 증발잔류물 검사는 원료 10 ㎖를 취하여 수욕상에서 105℃로 6시간 증발시킨 후 4~6 중량% 되도록 확인하였다.
⑻ 건조감량은 원료 5 g을 105℃에서 4시간 동안 가열하여 70℃가 되었을 때 80% 수준을 유지하도록 하였다.
이상과 같은 시험방법을 이용하여 확인한 건강기능성 식품으로서의 조직배양 산삼분말의 특성은 표 1과 같았다.
[표 1]
시험항목 시험방법 평균값 성상 4. 1) 항 황갈색의 점성분말, 특이한 냄새가 있음 확인시험 4. 2) 항 ① 적갈색 확인됨 4. 2) 항 ② 자색이 확인됨 4. 2) 항 ③ 적갈색 확인됨 4. 1) 항 ④ 적자색 확인됨 총사포닌 함량 (%) 4. 3) 항 7.0 pH 4. 4) 항 5.3 순도시험 Pb 4. 5) 항 ① 1.0 ppm As 4. 5) 항 ② 2 ppm 이하 증발잔류물 4. 6) 항 5.1 중량% 건조함량 4. 7) 항 73.2 중량%
성상은 황색~황갈색의 분말로 특이한 냄새가 있다. 확인시험 결과로는 가. 접계면은 적갈색을 띤다(사포닌류); 나. 액은 자색을 띤다(아미노산); 다. 접계면은 적갈색을 띤다(트리테르펜노이드); 라. 접계면은 적자색을 띤다(사카라이드). 조사포닌 함량은 원료에서 조사포닌 평균치가 6.0~8.0 중량%로 기준을 설정하였으며, 산도(pH)는 실험결과 시료의 평균 pH가 5.2로서 기준을 4.0~6.0으로 설정하였다. 순도시험은 중금속의 경우 실험치의 최저값은 0.6 ppm, 최대값은 1.6 ppm으로 이 원료의 중금속 기준은 3 ppm 미만으로 하였으며, 비소는 이 원료에서 기준을 2 ppm 이하로 설정하였다. 증발잔류물은 원료를 80~100℃의 온수로 추출한 조직배양산삼분말로서 실험 결과 시료의 증발잔류물 평균이 5.1 중량%로서 기준을 4~6 중량%로 설정하였다. 건조감량은 조직배양산삼 분말의 시료 건조함량은 평균이 73.2 중량%로서 기준을 70~80 중량%로 설정하였다.
<실시예 3> 산삼배양근 추출물의 진세노사이드 분석
식품공전과 기능성식품규격의 표준분석법에 따라 산삼배양근에 함유된 진세노사이드의 특성을 재배삼 및 홍삼과 비교 분석하였다. 간략하게는, 건조한 배양 산삼분말 2 g을 60℃에서 1시간 동안 80% 주정 40㎖로 2회 추출하여 여과한 다음 감압증류하고, HPLC용 증류수 50 ㎖에 용해시킨 것을 HPLC (Waters 2690 separation module; Waters 996 photodiode array detector; Waters millenium 2010 chromatography manager)를 이용하여 분석하였다. 이때 물과 아세토나이트릴(acetonitrile)의 비율을 조절하여 초기에는 86:14, 이후에는 acetonitrile의 함량을 높여가면서 분석하였다.
산삼배양근 추출물의 진세노사이드 특성을 도 1 및 도 2에서 살펴보면, 인삼과 홍삼의 조사포닌 함량은 4~5 중량%인데 비하여, 산삼배양근은 6~8 중량%로 그 함량이 높고, 특히 Rd의 함량이 높은 것으로 나타났다(도 1). 산삼배양근 HPLC를 이용한 총사포닌 분석에서 산삼배양근은 재배삼과 홍삼의 진세노사이드(ginsenosides) 함량 1-2 중량%보다 많은 2-3 중량%의 함량을 함유하고 있으며 사포닌의 종류가 더 다양하다(도 2). 또한 산삼배양근은 배양 과정 중에 물리 화학적인 스트레스를 줌으로써 생리활성 물질의 함량을 높일 수 있으며, 사포닌 디올과 트리올의 함량비를 조절할 수 있는 장점도 있다.
<실시예 4> 산삼배양근 추출물의 항산화 효과
상기 실시예 1에서 얻은 배양근 원료, 재배삼 및 홍삼을 환류냉각법을 이용하여 추출하였다. 즉, 조직배양한 산삼 부정근 40 g을 환류냉각관이 부착된 둥근 플라스크에 넣고, 70% 발효주정 280 ㎖를 첨가한 다음 70℃에서 2시간 동안 환류추출하였다. 상기와 동일한 방법으로 30%, 10%의 발효주정으로 2회 더 추출한 후, 필터페이퍼(Advantitic, Tokyo, Japan)로 여과하고 감압농축하여 산삼배양근 추출물을 수득하였다. 상기 추출물을 0.05, 0.1, 0.25, 0.5, 1.0, 2.0의 농도별로 처리하여 활성산소종의 소거능, 즉 DPPH에 대한 전자공여능(electron donating ability, EDA%)을 M.S. 블로이스의 방법(M.S. Blois, Nature 26: 1199, 1958)을 이용하여 조사하였다.
측정 결과를 도 2에서 살펴보면, DPPH의 소거활성으로 나타낸 황산화 효과는 산삼 배양근 추출물 CBN-2 및 CBN-3에서 월등히 높아서 산삼배양근은 환경오염이나 스트레스 등으로 현대인들에게 많이 생기는 활성산소종을 효과적으로 제거할 수 있는 효과가 있는 것으로 평가되었다.
The present invention for achieving the above object relates to a wild ginseng culture root extract containing a large amount of saponin, more specifically, inoculated into the medium and cultured in a bioreactor inoculated wild ginseng root roots grown by tissue culture, harvesting 10 days The ginseng culture root powder obtained by depleting nitrogen in the foreground medium and then cultivating is extracted by a warm extraction method or a reflux extraction method, and relates to a ginseng culture root extract having a high saponin content.
The wild ginseng cultured root powder of the present invention is yellow to yellowish brown powder, the average content of irradiated saponin is 6.0 ~ 8.0% by weight, the total saponin content is 2-3% by weight, and the dry content is 70-80% by weight. It is done.
In addition, the wild ginseng cultured powder is characterized in that the average acidity (pH) is 4.0 ~ 6.0.
In addition, the heavy metal standard of the wild ginseng cultured powder is characterized in that less than 3 ppm.
In addition, the evaporation residue of the wild ginseng cultured root powder is characterized in that 4 to 6% by weight.
Hereinafter, the configuration of the present invention will be described in more detail with reference to preferred embodiments, but these embodiments are only for illustrating the present invention specifically, the scope of the present invention is not limited by these examples, The scope shall be defined only by what is stated in the claims.
Example 1 Preparation of Wild Ginseng Cultured Root Extract
The 100-year-old wild ginseng harvested from Odaesan, Gangwon-do on October 25, 2002 was separated into brains, roots, and roots, sterilized and sterilized, and then slices were made into 2 ~ 3 mm2, followed by 2,4-dichlorophenoxy acetic acid. (2,4-dichlorophenoxyacetic acid), pichloram, and NAA (naphthalemeacetic acid) were added in amounts of 1-10 mg / l, and then inoculated in MS medium to induce callus. Induced callus was grown in MS medium to which 1.0 mg / L of 2,4-dichlorophenoxy acetic acid was added as a growth regulator, and then subcultured every two weeks to MS medium to which IBA was added in an amount of 5.0 mg / L. Transferred to form a root muscle. The formed root muscle is cut into 0.5 ~ 1 cm size and inoculated into MS medium with mineral concentration 1/2, pH 5.7, and sugar concentration 3% using a 10 ~ 20 L bioreactor. Proliferation was then used as seed for large-volume bioreactor culture. The seed was cut to a size of 1 to 2 cm and inoculated in a large-capacity air flotation balloon bioreactor of 200, 500, 1,000, 10,000 L scale. At this time, the medium composition was a liquid MS medium containing 5% sugar (Duchefa, Netherlands), and as a growth regulator was added 1.0-5.0 mg / l 3-indolbutyl acid (IBA). The initial pH of the medium was maintained at 5.8-6.0, the culture temperature was 22 ± 2 ° C, and the air injection amount was 0.1-0.3 vvm (volume / volume / min).
After 2 weeks of culture, the new root muscle began to form in the root muscle section, and the maximum growth occurred at 35-40 days of culture. After this period, nitrogen was depleted in medium to increase the total saponin content, and then cultured for 10 more days. Cultured roots derived from the brain head, main muscle, and root muscle were harvested and named as CBN-1, CBN-2, and CBN-3, respectively. The harvested sample was washed two to three times with tap water, dried at 50 ° C. for 24 hours, and then crushed with a grinder to obtain a powder raw material.
Example 2 Health Functional Food Characteristics of Tissue Cultured Wild Ginseng Powder
Tissue cultured wild ginseng powder was recognized for its quality as a health functional food. Since there was no reference to the health functional food process and process of cultured wild ginseng domestically and internationally, first of all, cosmetics were manufactured from cultured ginseng as raw materials. The permit was assessed for the health functional food characteristics by setting the test items, such as properties, identification, total saponin content, acidity, purity, evaporation residue, and drying loss, which were obtained from the KFDA.
The culture root material obtained in Example 1 was extracted using a warm extraction method. That is, 10 kg of wild ginseng root cultured from tissue culture was extracted at a temperature of 80-100 ° C for 6-8 ° C. At this time, the ratio of raw material and hot water was 1:20. Ethanol was removed with Hg and filtered to obtain about 10 kg of wild ginseng root extract.
The test items were examined as follows for the wild ginseng cultured root powder and extract.
O The appearance was observed by naked eye and judged as smell.
⑵ For the saponin test, 2 ml of acetic anhydride was added to 0.2 g of raw material, and heated for 2 minutes in a bath. Then, 0.5 ml of sulfuric acid was added to 1 ml of the filtrate. To confirm the amino acid, 1 ml of ninhydrin solution was added to 2 ml of the raw material, and the mixture was shaken and left to stand in boiling boiling water for 5 to 10 minutes. To confirm triterpenoids, 10 ml of the above extract was concentrated under reduced pressure, 10 ml of chloroform was added to the residue, followed by shaking. The mixture was filtered, and 0.5 ml of anhydrous acetic acid was added to the residue. Add to the surface.
확인 To confirm the saccharide, 2 ~ 3 drops of 5% α-naphthol ethanol TS was added to 0.5 ml, mixed, and added to 2 ml of sulfuric acid.
⑷ The total saponin content was analyzed according to the standard method of food industry.
⑸ Acidity (pH) was determined by measuring 5 g of the raw material and adding 50 ml of freshly distilled water after cooling to room temperature.
⑹ Purity test was carried out in accordance with the second method by taking 1 g of the raw material to check the heavy metal content. 2.0 ml of lead standard solution was added to the comparative solution (20 ppm or less) .In order to detect arsenic, 1 g of raw material was taken to make a sample solution according to the third method, and the test was carried out using the apparatus A. ).
⑺ evaporation residue test was to take 10 ㎖ of the raw material and evaporated at 105 ℃ in water bath for 6 hours and confirmed to be 4 ~ 6% by weight.
⑻ Loss on drying was maintained at 80% when 5g of raw material was heated at 105 ℃ for 4 hours to reach 70 ℃.
The characteristics of the tissue culture wild ginseng powder as a health functional food confirmed using the test method described above are shown in Table 1.
TABLE 1
Test Items Test Methods medium Constellation 4. 1) Yellowish brown powdery powder with an unusual smell Test 4. 2) Item Maroon confirmed 4. 2) Clause Purple checked 4. 2) Item ③ Maroon confirmed 4. 1) Clause ④ Fuchsia confirmed Total Saponin Content (%) 4. 3) 7.0 pH 4. 4) 5.3 Purity test Pb 4.5) Item 1.0 ppm As 4. 5) Clause 2 ppm or less Evaporation residue 4. 6) 5.1 wt% Dry content 4. 7) 73.2% by weight
Appearance is yellow to yellow brown powder with peculiar smell. As a result of confirmation test The interface is reddish brown (saponins); I. Solution is purple (amino acid); All. The interface is reddish brown (triterpenoids); la. The interface is reddish violet (saccharide). The irradiated phosphonine content was set to 6.0 to 8.0 wt% of the average irradiated phosphonine in the raw material, and the pH (pH) was set to 4.0 to 6.0 as the average pH of the sample. Purity test showed that the minimum value of the test value was 0.6 ppm, the maximum value was 1.6 ppm for the heavy metals, and the reference level of the heavy metals of this raw material was less than 3 ppm, and arsenic was set to 2 ppm or less for this raw material. Evaporation residue is a tissue culture production three powder extracted raw material with hot water of 80 ~ 100 ℃, the average of the evaporation residue of the sample was set to 4 to 6% by weight as the average of 5.1% by weight. The drying loss of the sample of tissue culture ginseng powder was set as the average of 73.2% by weight, 70 to 80% by weight.
Example 3 Ginsenoside Analysis of Wild Ginseng Cultured Root Extract
The characteristics of ginsenosides in wild ginseng cultured roots were compared with those of cultivated ginseng and red ginseng according to the standard analysis method of Food Code and functional food standard. Briefly, 2 g of dry cultured wild ginseng powder was extracted twice with 40 ml of 80% alcohol for 1 hour at 60 ° C., filtered and distilled under reduced pressure, and then dissolved in 50 ml of distilled water for HPLC. HPLC (Waters 2690 separation module; The analysis was performed using a Waters 996 photodiode array detector (Waters millenium 2010 chromatography manager). At this time, by adjusting the ratio of water and acetonitrile (acetonitrile) was initially analyzed at 86:14, after increasing the content of acetonitrile.
Looking at the ginsenoside characteristics of the ginseng culture root extract in Figures 1 and 2, the ginseng and red ginseng irradiated with 4 ~ 5% by weight, the wild ginseng cultured 6 ~ 8% by weight, especially the content of Rd The content was found to be high (FIG. 1). In total saponin analysis using wild ginseng root HPLC, wild ginseng root contains 2-3% by weight, more than 1-2% by weight of ginsenosides of cultivated ginseng and red ginseng. 2). In addition, the wild ginseng culture root can increase the content of physiologically active substances by physicochemical stress during the culture process, and has the advantage of controlling the content ratio of saponin diol and triol.
Example 4 Antioxidant Effect of Wild Ginseng Cultured Root Extract
The culture root material, cultivated ginseng and red ginseng obtained in Example 1 were extracted by reflux cooling. That is, 40 g of cultured wild ginseng root ginseng was placed in a round flask with a reflux condenser tube, 280 ml of 70% fermented alcohol was added thereto, and reflux extraction was performed at 70 ° C. for 2 hours. After extracting twice more with fermentation alcohol of 30%, 10% by the same method as above, and filtered with filter paper (Advantitic, Tokyo, Japan) and concentrated under reduced pressure to obtain a wild ginseng root extract. The extract was treated with concentrations of 0.05, 0.1, 0.25, 0.5, 1.0, 2.0 to determine the scavenging ability of reactive oxygen species, ie, electron donating ability (EDA%) for DPPH (MS Blois, Nature). 26: 1199, 1958).
2, the sulfated effect of DPPH scavenging activity is significantly higher in wild ginseng cultured root extracts CBN-2 and CBN-3, and the wild ginseng cultured root effectively removes free radicals that occur in modern people due to environmental pollution or stress. It was evaluated that there was an effect that could be eliminated.

이상에서 상술한 바와 같이 본 발명에 따른 산삼배양근 추출물은 주요 약리 활성성분인 사포닌이 다량 함유된 기능성식품 소재로서, 산삼 사포닌에서 유래한 다양한 건강상 유익뿐만 아니라, 특히 현대인에게 많이 생기는 활성산소종을 효과적으로 제거할 수 있는 효과가 있는 것으로 평가되었다.As described above, the wild ginseng cultured root extract according to the present invention is a functional food material containing a large amount of saponin, which is a major pharmacologically active ingredient, and not only various health benefits derived from wild ginseng saponin, but also active oxygen species, which are particularly produced in modern people. It was evaluated to have an effect that can be effectively removed.

Claims (4)

조직배양에 의해 증식된 산삼 부정근을 배지에 접종하고 생물반응기내에서 배양하되, 수확 10일전경 배지내 질소를 고갈시킨 다음 배양하여 수득한 산삼배양근 분말을 가온추출법 또는 냉각환류추출법으로 추출하여 사포닌 함량이 높은 산삼배양근 추출물에 있어서, The wild ginseng root roots grown by tissue culture were inoculated into the culture medium and cultured in a bioreactor, and the wild ginseng cultured root powder obtained by culturing the nitrogen in the medium around 10 days before harvesting was extracted by a warm extraction method or a reflux extraction method. In this high ginseng cultured root extract, 상기 산삼배양근 분말은 황색~황갈색의 분말의 성상에, 조사포닌의 평균 함량이 6.0~8.0 중량%, 총사포닌 함량이 2~3 중량%이며, 건조함량이 70~80 중량%인 것을 특징으로 하는 진세노사이드 Rd의 함량이 특징적으로 높고 사포닌 함량이 높은 산삼배양근 추출물.The wild ginseng cultured powder is yellow to yellowish brown powder, the average content of the irradiated saponin 6.0 ~ 8.0 wt%, the total saponin content is 2-3 wt%, characterized in that the dry content is 70 ~ 80 wt% Ginseng culture root extract with high content of ginsenoside Rd and high saponin content. 제1항에 있어서, 상기 산삼배양근 분말의 평균 산도(pH)가 4.0~6.0인 것을 특징으로 하는 진세노사이드 Rd의 함량이 특징적으로 높고 사포닌 함량이 높은 산삼배양근 추출물.The wild ginseng cultured root extract of claim 1, wherein the content of ginsenoside Rd is high and saponin content is characterized in that the average acidity (pH) of the wild ginseng cultured root powder is 4.0 to 6.0. 제1항 또는 제2항에 있어서, 상기 산삼배양근 분말의 중금속 기준이 3 ppm 미만인 것을 특징으로 하는 진세노사이드 Rd의 함량이 특징적으로 높고 사포닌 함량이 높은 산삼배양근 추출물.The ginseng cultured root extract according to claim 1 or 2, wherein the content of ginsenoside Rd is high and saponin content is characterized in that the heavy metal standard of the wild ginseng cultured root powder is less than 3 ppm. 제3항에 있어서, 상기 산삼배양근 분말의 증발잔류물은 4~6 중량%인 것을 특징으로 하는 진세노사이드 Rd의 함량이 특징적으로 높고 사포닌 함량이 높은 산삼배양근 추출물.According to claim 3, The evaporation residue of the wild ginseng cultured root powder is characterized in that the content of ginsenoside Rd is high and saponin content of high ginseng culture, characterized in that 4 ~ 6% by weight.
KR1020060091978A 2006-09-21 2006-09-21 Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin KR100711954B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060091978A KR100711954B1 (en) 2006-09-21 2006-09-21 Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060091978A KR100711954B1 (en) 2006-09-21 2006-09-21 Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin

Publications (1)

Publication Number Publication Date
KR100711954B1 true KR100711954B1 (en) 2007-05-02

Family

ID=38269162

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060091978A KR100711954B1 (en) 2006-09-21 2006-09-21 Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin

Country Status (1)

Country Link
KR (1) KR100711954B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115837041A (en) * 2022-12-14 2023-03-24 通化本草生物科技有限公司 Fermentation medium for ginseng tissue culture adventitious roots and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010044235A (en) * 2001-01-19 2001-06-05 백기엽 The method for increasing saponin content and controlling the ratio of triol and diol during adventitus roots culture in ginseng
KR20060062692A (en) * 2004-12-06 2006-06-12 주식회사 씨비엔바이오텍 Method for preparing an extract of tissue cultured mountain ginseng having high content saponin and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010044235A (en) * 2001-01-19 2001-06-05 백기엽 The method for increasing saponin content and controlling the ratio of triol and diol during adventitus roots culture in ginseng
KR20060062692A (en) * 2004-12-06 2006-06-12 주식회사 씨비엔바이오텍 Method for preparing an extract of tissue cultured mountain ginseng having high content saponin and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115837041A (en) * 2022-12-14 2023-03-24 通化本草生物科技有限公司 Fermentation medium for ginseng tissue culture adventitious roots and application thereof
CN115837041B (en) * 2022-12-14 2024-04-26 通化本草生物科技有限公司 Fermentation medium for tissue culture adventitious roots of ginseng and application thereof

Similar Documents

Publication Publication Date Title
CN101768514B (en) Alhagi sparsifolia extract and preparation method and application thereof
EP2003988B1 (en) Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea
KR101566320B1 (en) Cosmetic composition comprising an Impatiens balsamina L, Maca, Rosa multiflora Thunberg, Eryobotrya japonica and Pachyrrhizus erosus Complex-fermented extract
JP7471393B2 (en) Tea composition having preventive or ameliorative effects on respiratory diseases and pharmaceutical composition containing the same
KR101794006B1 (en) Anti inflammatory comprising plant extract
KR20130121324A (en) Composition for preventing and treating hangover comprising extracts of leaves of perilla frutescens britton var
JP5546040B2 (en) Plum extract and its production method and use
KR102012872B1 (en) High concentrate for beverage containing black raspberry, plantaginis asiatica l., schizandra chinensis, lycii fructus and torilis japonica decandolle and the high concentrate for beverage prepared from the same
KR20230052700A (en) Anti-pollution cosmetic composition containing camellia extract, aurea helianthus extract, carpinus tschonoskii extract, silkworm extract and centella asiatica extract
KR20110048401A (en) Method for preparing the extract fortified with chalcones from by-product of Angelica keiskei juice
Wu et al. Efficient extraction of caffeic acid derivatives from adventitious roots of Echinacea purpurea
KR101706017B1 (en) Hepatoprotective composition comprising extracts of fruits of stauntonia hexaphylla for preventing alcoholic liver injury
KR102511861B1 (en) Composition for strengthening muscle strength comprising a complex extract of Angelica keiskei and Morus alba leaves
KR100711954B1 (en) Extract of tissue cultured mountain ginseng(panax schinseng ness) having high content saponin
KR101968891B1 (en) Composition for treating hangover comprising extracts of fruits of stauntonia hexaphylla
KR101958439B1 (en) Method for producing Hovenia dulcis beverage product comprising Hovenia dulcis mixed concentrate
KR101960037B1 (en) Method for producing stick type red ginseng product comprising red ginseng mixed concentrate
KR101773318B1 (en) Hepatoprotective composition comprising extracts of fruits of stauntonia hexaphylla for preventing alcoholic liver injury
KR20100116919A (en) Compositions comprising extract from codonopsis lanceolata for preventing or treating obesity, hyperlipidemia or fatty liver
Pingili et al. Evaluation of the polyherbal extract for antioxidant, anticancer and antidiabetic activity
KR101734022B1 (en) Method of preparing combined extract powder of fermented scutellariae radix and gastrodiae rhizoma from compounding solution of micro-organism and natural enzyne
CN113292622B (en) Method for extracting beta-sitosterol from pimpinella brachycarpa and application of beta-sitosterol
TWI779742B (en) Uses of a qingyin tea fermentation in preparing composition for reducing lipid and stabilizing blood sugar
KR102468019B1 (en) Plant mixed concentrate mainly containing Korean Dendropanax and foods using the concentrate
KR102557683B1 (en) Fermentation composition of sprouts of mountain-cultivated ginseng having increased ginsenoside Rg3 and Protopanaxadiol, Rutin, Chlorogenic acid and Essential amid acids by using Tricholoma matsutake mycelium and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130419

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140418

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150420

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160420

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170420

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180316

Year of fee payment: 12